Nick Daneman
Impact in
- Applied Microbiology and Biotechnology top 0.02%
- Antibiotic Use and Resistance
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Use and Resistance 85
-
- Clostridium difficile and Clostridium perfringens research 24
- Antimicrobial Resistance in Staphylococcus 14
- Co-authors
- Kevin Antoine Brown (77 shared papers)Derek R. MacFadden (50 shared papers)Bradley J. Langford (62 shared papers)Valerie Leung (34 shared papers)Miranda M. So (7 shared papers)Sumit Raybardhan (6 shared papers)Duncan J. Westwood (3 shared papers)Marion Elligsen (29 shared papers)
- Journals
- Clinical Infectious Diseases (39 papers)Clinical Microbiology and Infection (29 papers)Infection Control and Hospital Epidemiology (19 papers)PLoS ONE (14 papers)Open Forum Infectious Diseases (13 papers)
- Partner nations
- CanadaUnited StatesAustralia
In The Last Decade
Nick Daneman
300 papers receiving 11.3k citations
Nick Daneman's Hit Papers
Peers
Comparison fields: 5 of 162
- Applied Microbiology and Biotechnology 3.0k
- Molecular Medicine 1.2k
- Critical Care and Intensive Care Medicine 1.0k
- Infectious Diseases 2.8k
- Clinical Biochemistry 938
Countries citing papers authored by Nick Daneman
This map shows the geographic impact of Nick Daneman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nick Daneman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nick Daneman more than expected).
Fields of papers citing papers by Nick Daneman
This network shows the impact of papers produced by Nick Daneman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nick Daneman. The network helps show where Nick Daneman may publish in the future.
Co-authors
The 25 scholars most cited alongside Nick Daneman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 321 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis Hit paper breakdown → | 2020 | 1159 |
| 2 | Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis Hit paper breakdown → | 2021 | 611 |
| 3 | Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance Hit paper breakdown → | 2018 | 608 |
| 4 | Meta-Analysis of Antibiotics and the Risk of Community-Associated Clostridium difficile Infection Hit paper breakdown → | 2013 | 474 |
| 5 | 2011 | 324 | |
| 6 | 2016 | 226 | |
| 7 | Estimates of SARS-CoV-2 Omicron Variant Severity in Ontario, Canada Hit paper breakdown → | 2022 | 224 |
| 8 | 2013 | 208 | |
| 9 | 2021 | 197 | |
| 10 | Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysis Hit paper breakdown → | 2022 | 175 |
| 11 | 2012 | 167 | |
| 12 | 2021 | 163 | |
| 13 | 2020 | 162 | |
| 14 | 2011 | 152 | |
| 15 | 2015 | 133 | |
| 16 | 2021 | 133 | |
| 17 | 2014 | 129 | |
| 18 | 2020 | 125 | |
| 19 | Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysis Hit paper breakdown → | 2023 | 119 |
| 20 | 2013 | 112 |
About Nick Daneman
Nick Daneman is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases, Clinical Biochemistry, Epidemiology and Critical Care and Intensive Care Medicine, having authored 321 papers that have together received 11.6k indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (85 papers), Bacterial Identification and Susceptibility Testing (35 papers), Urinary Tract Infections Management (25 papers), Clostridium difficile and Clostridium perfringens research (24 papers), Antibiotic Resistance in Bacteria (15 papers), Antimicrobial Resistance in Staphylococcus (14 papers), Nosocomial Infections in ICU (12 papers) and Antibiotics Pharmacokinetics and Efficacy (11 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (3.0k citations), Molecular Medicine (1.2k citations), Critical Care and Intensive Care Medicine (1.0k citations), Infectious Diseases (2.8k citations) and Clinical Biochemistry (938 citations). Nick Daneman has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Kevin Antoine Brown, Derek R. MacFadden, Bradley J. Langford, Valerie Leung, Miranda M. So, Sumit Raybardhan, Duncan J. Westwood, Marion Elligsen, David N. Fisman and Andrew E. Simor. Their work appears in journals such as Clinical Infectious Diseases, Clinical Microbiology and Infection, Infection Control and Hospital Epidemiology, PLoS ONE and Open Forum Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.